Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study

Access to diphtheria antitoxin for therapy and diagnostics

(2014) L Both et al.   Eurosurveillance

Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland

(2013) Aleksandra A Zasada et al.   BMC INFECTIOUS DISEASES

Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine Administered According to 4 Different Primary Immunization Schedules in Infants

(2013) Judith Spijkerman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparative seroepidemiology of diphtheria in six European countries and Israel

(2012) P. DI GIOVINE et al.   EPIDEMIOLOGY AND INFECTION

Immunity to tetanus and diphtheria in the UK in 2009

(2012) Karen S. Wagner et al.   VACCINE

Improved Specificity of a Multiplex Immunoassay for Quantitation of Anti-Diphtheria Toxin Antibodies with the Use of Diphtheria Toxoid

(2011) Pieter G. M. van Gageldonk et al.   Clinical and Vaccine Immunology

Measuring vaccination coverage in a hard to reach minority

(2011) W. L. M. Ruijs et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

Immunity against diphtheria among children and adults in Izmir, Turkey

(2011) Zafer Kurugöl et al.   VACCINE

External Quality Assessment for the Determination of Diphtheria Antitoxin in Human Serum

(2010) P. Di Giovine et al.   Clinical and Vaccine Immunology

A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use

(2009) K.S. Wagner et al.   VACCINE

High tetanus and diphtheria antitoxin concentrations in Finnish adults—Time for new booster recommendations?

(2009) R.-M. Ölander et al.   VACCINE